Infantile haemangiomas (IH) are the most common benign tumours of infancy. Although
most IH are innocuous and 85–90% regress spontaneously, some may become life‐or …

Aims Propranolol may have shown excellent results as a first line therapy in infantile
haemangiomas (IHs) at all sites in the body, but this conclusion remains controversial. In an …

Background The aetiology and exact incidence of infantile haemangiomas (IHs) are
unknown. Prior studies have noted immunohistochemical and biological characteristics …

Hemangioma of infancy is a condition that may be associated with significant morbidity.
While evidence most supports the use of corticosteroids, there is no well‐defined or Federal …

Infantile hemangiomas (IHs) are the most common tumor of infancy and have been
estimated to occur in 4% of infants. Only two previous incidence studies of IH in a healthy …

VEGFR-2 is the primary regulator of angiogenesis, the development of new blood vessels
from pre-existing ones. VEGFR-2 has been hypothesized to be monomeric in the absence of …

The goal of the current study was to compare the clinical effectiveness of oral propranolol
with that of oral prednisone in the treatment of infantile hemangiomas (IH). Patients treated …

A hallmark of infantile hemangioma, the most common tumor of infancy, is its dramatic
growth after birth, by diffuse proliferation of immature endothelial cells, followed by …

The article presents the author's views regarding the usage of propranolol as a treatment for
infantile hemangiomas. He says the propranolol is a non-selective beta-blocker which have …

Vascular malformations and hemangiomas are common in children but remain a source of
confusion during diagnosis, in part because of the lack of a uniform terminology. With the …